Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/89480
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorMorales, Albert-
dc.contributor.authorGoñi, Félix M.-
dc.contributor.authorFernández-Checa, José C.-
dc.date.accessioned2014-01-15T12:09:41Z-
dc.date.available2014-01-15T12:09:41Z-
dc.date.issued2007-
dc.identifierdoi: 10.1007/s10495-007-0721-0-
dc.identifierissn: 1360-8185-
dc.identifiere-issn: 1573-675X-
dc.identifier.citationApoptosis 12(5): 923-939 (2007)-
dc.identifier.urihttp://hdl.handle.net/10261/89480-
dc.description.abstractSphingolipids (SLs) have been considered for many years as predominant building blocks of biological membranes with key structural functions and little relevance in cellular signaling. However, this view has changed dramatically in recent years with the recognition that certain SLs such as ceramide, sphingosine 1-phosphate and gangliosides, participate actively in signal transduction pathways, regulating many different cell functions such as proliferation, differentiation, adhesion and cell death. In particular, ceramide has attracted considerable attention in cell biology and biophysics due to its key role in the modulation of membrane physical properties, signaling and cell death regulation. This latter function is largely exerted by the ability of ceramide to activate the major pathways governing cell death such as the endoplasmic reticulum and mitochondria. Overall, the evidence so far indicates a key function of SLs in disease pathogenesis and hence their regulation may be of potential therapeutic relevance in different pathologies including liver diseases, neurodegeneration and cancer biology and therapy. © 2007 Springer Science + Business Media, LLC.-
dc.description.sponsorshipThe work presented was supported in part by the Research Center for Liver and Pancreatic Diseases, P50 AA 11999; and grant 1R21 AA014135, funded by the US National Institute on Alcohol Abuse and Alcoholism; Plan Nacional de I+D grants SAF (2003-04974; 2006-06780); and Red Temática de Investigación Cooperativa G03/015, Red de Centros C03/02, PI 05/1285 and FIS (06/0395) supported by Instituto de Salud Carlos III, Spain, and the European Lipidomics Initiative (Elife). A.M. is a Ramon y Cajal investigator.-
dc.language.isoeng-
dc.publisherSpringer Nature-
dc.rightsclosedAccess-
dc.subjectMitochondria-
dc.subjectCeramide-
dc.subjectTransbilayer trafficking-
dc.subjectEndoplasmic reticulum-
dc.subjectGangliosides-
dc.subjectMembranes-
dc.titleSphingolipids and cell death-
dc.typeartículo-
dc.identifier.doi10.1007/s10495-007-0721-0-
dc.date.updated2014-01-15T12:09:42Z-
dc.description.versionPeer Reviewed-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairetypeartículo-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
Aparece en las colecciones: (IIBB) Artículos
(IBF) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

197
checked on 20-abr-2024

WEB OF SCIENCETM
Citations

183
checked on 28-feb-2024

Page view(s)

413
checked on 23-abr-2024

Download(s)

130
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.